| UHC Commercial Medical & Drug | Leqvio® (Inclisiran) – Commercial Medical Benefit Drug Policy | 2026-06-01 |
| UHC Commercial Medical & Drug | Manipulative Therapy – Commercial and Individual Exchange Medical Policy | 2026-06-01 |
| UHC Commercial Medical & Drug | Negative Pressure Wound Therapy – Commercial and Individual Exchange Medical Policy | 2026-06-01 |
| UHC Commercial Medical & Drug | Ocular Photoscreening – Commercial and Individual Exchange Medical Policy | 2026-06-01 |
| UHC Commercial Medical & Drug | Omnibus Codes – Commercial and Individual Exchange Medical Policy | 2026-06-01 |
| UHC Commercial Medical & Drug | Pneumatic Compression Devices – Commercial and Individual Exchange Medical Policy | 2026-06-01 |
| UHC Commercial Medical & Drug | Prostate Surgeries and Interventions – Commercial and Individual Exchange Medical Policy | 2026-06-01 |
| UHC Commercial Medical & Drug | Spevigo® (Spesolimab-Sbzo) – IV and Subcutaneous Formulations (for UHCWest Only) – Commercial Medical Benefit Drug Policy | 2026-06-01 |
| UHC Commercial Medical & Drug | Surgery of the Knee – Commercial and Individual Exchange Medical Policy | 2026-06-01 |
| BCBS Louisiana | Chelation Therapy | 2026-06-01 |